Hims & Hers Health, Inc. (HIMS)
Every FINRA and SEC series the site collects for Hims & Hers Health, Inc.: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on NYSE, classified by the SEC as services-offices & clinics of doctors of medicine.
58.7M
Short interest
settlement 2026-08-14
4.5
Days to cover
-5.7% vs prior
64.8%
Short share of volume
2026-09-11
4,416
Fails to deliver
settlement 2026-08-14
-$3.3M
Insider flow, 90 days
0 buys, 4 sells
As of 2026-09-11.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 14 August 2026, short interest in HIMS is 58,674,597 shares, down 2,735,524 shares over the last month. Over the last 48 readings it ranged from 24,764,222 shares (30 September 2024) to 84,964,491 shares (27 February 2026). At the reported average volume of 13.1M shares a day that is 4.5 days to cover.
Embed this chartfree, with the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/hims" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-14 | 58,674,597 | -5.7% | 13,079,862 | 4.49 |
| 2026-07-31 | 62,215,733 | +1.3% | 16,751,153 | 3.71 |
| 2026-07-15 | 61,410,121 | +0.4% | 13,580,710 | 4.52 |
| 2026-06-30 | 61,166,806 | -6.6% | 18,918,072 | 3.23 |
| 2026-06-15 | 65,472,703 | +4.6% | 18,560,107 | 3.53 |
| 2026-05-29 | 62,610,734 | -1.2% | 19,908,553 | 3.14 |
| 2026-05-15 | 63,372,020 | +0.3% | 25,855,597 | 2.45 |
| 2026-04-30 | 63,160,154 | -9.5% | 42,790,298 | 1.48 |
| 2026-04-15 | 69,774,819 | -2.2% | 23,188,241 | 3.01 |
| 2026-03-31 | 71,359,926 | -14.3% | 28,538,083 | 2.50 |
| 2026-03-13 | 83,286,092 | -2.0% | 63,754,242 | 1.31 |
| 2026-02-27 | 84,964,491 | +4.9% | 32,934,660 | 2.58 |
| 2026-02-13 | 81,010,101 | +5.5% | 47,181,723 | 1.72 |
| 2026-01-30 | 76,761,792 | +6.2% | 17,577,597 | 4.37 |
| 2026-01-15 | 72,251,095 | +7.7% | 16,419,348 | 4.40 |
| 2025-12-31 | 67,096,243 | +3.5% | 10,834,044 | 6.19 |
| 2025-12-15 | 64,816,789 | -3.7% | 14,009,237 | 4.63 |
| 2025-11-28 | 67,327,436 | -0.3% | 20,311,018 | 3.31 |
| 2025-11-14 | 67,552,266 | -3.7% | 34,326,686 | 1.97 |
| 2025-10-31 | 70,158,018 | +4.9% | 26,689,929 | 2.63 |
| 2025-10-15 | 66,883,420 | -5.8% | 30,028,606 | 2.23 |
| 2025-09-30 | 71,013,939 | +6.7% | 28,229,618 | 2.52 |
| 2025-09-15 | 66,534,489 | -10.8% | 29,826,022 | 2.23 |
| 2025-08-29 | 74,635,929 | +6.3% | 22,509,144 | 3.32 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 11 September 2026, the short share of HIMS volume is 64.8%, down 1.5 points over the last five sessions. Over the last 52 readings it ranged from 40.0% (31 July 2026) to 70.0% (9 September 2026). The latest reading is 4.0 points above the 30-session average of 60.8%, on 3.0M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-11 | 1.9M | 3.0M | 64.8% | 440 |
| 2026-09-10 | 1.8M | 2.8M | 65.5% | 2,809 |
| 2026-09-09 | 2.8M | 4.0M | 70.0% | 4,532 |
| 2026-09-08 | 2.2M | 3.5M | 60.9% | 2,356 |
| 2026-09-04 | 2.1M | 3.0M | 67.8% | 23,294 |
| 2026-09-03 | 4.0M | 6.1M | 66.3% | 2,714 |
| 2026-09-02 | 2.2M | 3.5M | 62.7% | 12,644 |
| 2026-09-01 | 2.0M | 3.2M | 61.4% | 9,464 |
| 2026-08-31 | 2.3M | 3.8M | 61.6% | 2,143 |
| 2026-08-28 | 4.4M | 7.3M | 60.8% | 14,996 |
| 2026-08-27 | 2.6M | 4.3M | 60.2% | 20,093 |
| 2026-08-26 | 3.1M | 5.0M | 60.7% | 7,799 |
| 2026-08-25 | 2.8M | 4.6M | 60.6% | 387,991 |
| 2026-08-24 | 4.5M | 6.9M | 64.7% | 342,514 |
| 2026-08-21 | 4.8M | 7.1M | 67.5% | 8,115 |
| 2026-08-20 | 4.6M | 7.7M | 60.2% | 7,366 |
| 2026-08-19 | 4.6M | 8.1M | 56.0% | 9,337 |
| 2026-08-18 | 2.0M | 3.5M | 56.7% | 11,750 |
| 2026-08-17 | 2.6M | 4.7M | 56.1% | 18,175 |
| 2026-08-14 | 2.7M | 4.2M | 63.7% | 3,242 |
| 2026-08-13 | 3.4M | 5.6M | 60.9% | 9,224 |
| 2026-08-12 | 4.4M | 7.3M | 59.9% | 10,094 |
| 2026-08-11 | 5.9M | 9.7M | 60.7% | 17,919 |
| 2026-08-10 | 3.9M | 5.7M | 68.2% | 7,346 |
| 2026-08-07 | 1.7M | 2.9M | 59.6% | 18,533 |
| 2026-08-06 | 2.1M | 3.2M | 64.5% | 15,802 |
| 2026-08-05 | 2.0M | 3.4M | 59.1% | 396 |
| 2026-08-04 | 2.5M | 4.3M | 57.1% | 8,265 |
| 2026-08-03 | 2.8M | 6.1M | 46.8% | 10,410 |
| 2026-07-31 | 2.4M | 6.1M | 40.0% | 6,461 |
Fails to deliver
SEC, by settlement date. JSONAs of 14 August 2026, the fails-to-deliver balance in HIMS is 4,416 shares, up 4,216 shares over the last settlement date. Over the last 52 readings it ranged from 91 shares (24 July 2026) to 479,427 shares (30 April 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-14 | 4,416 | $28.77 | $127K |
| 2026-08-10 | 200 | $31.59 | $6K |
| 2026-08-06 | 573 | $31.65 | $18K |
| 2026-08-05 | 1,121 | $32.16 | $36K |
| 2026-08-04 | 15,159 | $30.82 | $467K |
| 2026-08-03 | 61,579 | $27.77 | $1.7M |
| 2026-07-30 | 19,919 | $25.00 | $498K |
| 2026-07-29 | 19,870 | $29.32 | $583K |
| 2026-07-28 | 3,260 | $30.24 | $99K |
| 2026-07-24 | 91 | $32.74 | $3K |
| 2026-07-23 | 1,252 | $31.68 | $40K |
| 2026-07-22 | 1,782 | $32.73 | $58K |
| 2026-07-20 | 28,303 | $32.84 | $929K |
| 2026-07-17 | 10,189 | $33.68 | $343K |
| 2026-07-16 | 139,472 | $37.17 | $5.2M |
| 2026-07-15 | 3,294 | $35.15 | $116K |
| 2026-07-14 | 28,126 | $34.38 | $967K |
| 2026-07-13 | 38,246 | $34.38 | $1.3M |
| 2026-07-10 | 28,399 | $35.45 | $1.0M |
| 2026-07-09 | 8,532 | $36.07 | $308K |
| 2026-07-08 | 48,845 | $36.17 | $1.8M |
| 2026-07-07 | 15,627 | $38.28 | $598K |
| 2026-07-06 | 86,881 | $36.80 | $3.2M |
| 2026-07-02 | 131,256 | $37.57 | $4.9M |
| 2026-07-01 | 3,137 | $34.67 | $109K |
| 2026-06-30 | 53,821 | $33.39 | $1.8M |
| 2026-06-29 | 270,735 | $33.94 | $9.2M |
| 2026-06-26 | 68,641 | $32.71 | $2.2M |
| 2026-06-25 | 89,017 | $32.70 | $2.9M |
| 2026-06-24 | 26,254 | $32.96 | $865K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at HIMS reported 4 open-market sells worth $3.3M in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: Okupe Oluyemi (Chief Financial Officer) on 2026-08-19.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-19 | Okupe Oluyemi | Chief Financial Officer | Sell | 5K | $29.99 | $148K | 264K |
| 2026-08-19 | Okupe Oluyemi | Chief Financial Officer | Option exercise | 5K | $5.01 | $25K | 269K |
| 2026-08-19 | Boughton Soleil | Chief Legal Officer | Sell | 25K | $27.55 | $692K | 314K |
| 2026-08-18 | Autor Deborah M. | Chief Policy Officer | Sell | 17K | $27.85 | $467K | 49K |
| 2026-06-18 | Okupe Oluyemi | Chief Financial Officer | Sell | 55K | $35.09 | $1.9M | 229K |
| 2026-05-26 | WELLS DAVID B | n/a | Buy | 48K | $24.23 | $1.2M | 224K |
| 2026-05-18 | Okupe Oluyemi | Chief Financial Officer | Sell | 8K | $23.64 | $188K | 263K |
| 2026-05-18 | Okupe Oluyemi | Chief Financial Officer | Option exercise | 8K | $5.01 | $40K | 271K |
| 2026-04-20 | Okupe Oluyemi | Chief Financial Officer | Sell | 20K | $29.96 | $589K | 263K |
| 2026-04-20 | Okupe Oluyemi | Chief Financial Officer | Option exercise | 7K | $11.53 | $81K | 283K |
| 2026-04-20 | Okupe Oluyemi | Chief Financial Officer | Option exercise | 6K | $5.01 | $28K | 276K |
| 2026-04-20 | Boughton Soleil | Chief Legal Officer | Sell | 9K | $30.00 | $284K | 299K |
| 2026-04-17 | Okupe Oluyemi | Chief Financial Officer | Sell | 18K | $27.83 | $501K | 270K |
| 2026-04-17 | Okupe Oluyemi | Chief Financial Officer | Option exercise | 6K | $5.01 | $31K | 288K |
| 2026-04-16 | Okupe Oluyemi | Chief Financial Officer | Sell | 37K | $25.90 | $956K | 282K |
| 2026-04-06 | Okupe Oluyemi | Chief Financial Officer | Sell | 4K | $19.98 | $79K | 319K |
| 2026-04-06 | Okupe Oluyemi | Chief Financial Officer | Option exercise | 4K | $5.01 | $20K | 323K |
| 2026-03-20 | Okupe Oluyemi | Chief Financial Officer | Sell | 9K | $23.77 | $219K | 319K |
| 2026-03-20 | Okupe Oluyemi | Chief Financial Officer | Option exercise | 4K | $5.01 | $22K | 328K |
| 2026-03-17 | Chi Michael | Chief Operating Officer | Sell | 97K | $24.69 | $2.4M | 407K |
| 2026-03-17 | Boughton Soleil | Chief Legal Officer | Sell | 5K | $24.69 | $119K | 309K |
| 2026-03-17 | Becklund Irene | PAO | Sell | 6K | $24.69 | $137K | 9K |
| 2026-03-13 | Okupe Oluyemi | Chief Financial Officer | Tax withholding | 226K | $24.77 | $5.6M | 276K |
| 2026-03-13 | Dudum Andrew | Chief Executive Officer | Tax withholding | 436K | $24.77 | $10.8M | 1.2M |
| 2026-03-13 | Chi Michael | Chief Operating Officer | Tax withholding | 199K | $24.77 | $4.9M | 472K |
| 2026-03-13 | Boughton Soleil | Chief Legal Officer | Tax withholding | 147K | $24.77 | $3.6M | 294K |
| 2026-02-27 | Boughton Soleil | Chief Legal Officer | Sell | 5K | $15.21 | $71K | 441K |
| 2026-02-23 | Okupe Oluyemi | Chief Financial Officer | Grant | 411K | $0.00 | $0 | 502K |
| 2026-02-23 | Dudum Andrew | Chief Executive Officer | Grant | 794K | $0.00 | $0 | 1.7M |
| 2026-02-23 | Chi Michael | Chief Operating Officer | Grant | 365K | $0.00 | $0 | 670K |
| 2026-02-23 | Boughton Soleil | Chief Legal Officer | Grant | 274K | $0.00 | $0 | 446K |
| 2026-02-03 | Okupe Oluyemi | Chief Financial Officer | Sell | 5K | $26.44 | $139K | 92K |
| 2026-02-03 | Okupe Oluyemi | Chief Financial Officer | Option exercise | 5K | $5.01 | $26K | 97K |
| 2026-01-20 | Okupe Oluyemi | Chief Financial Officer | Sell | 9K | $30.34 | $275K | 92K |
| 2026-01-20 | Okupe Oluyemi | Chief Financial Officer | Option exercise | 2K | $11.53 | $20K | 101K |
| 2026-01-20 | Okupe Oluyemi | Chief Financial Officer | Option exercise | 7K | $5.01 | $37K | 99K |
| 2026-01-05 | Okupe Oluyemi | Chief Financial Officer | Sell | 9K | $33.79 | $306K | 92K |
| 2026-01-05 | Okupe Oluyemi | Chief Financial Officer | Option exercise | 4K | $11.53 | $44K | 101K |
| 2026-01-05 | Okupe Oluyemi | Chief Financial Officer | Option exercise | 2K | $5.01 | $11K | 97K |
| 2025-12-22 | Okupe Oluyemi | Chief Financial Officer | Sell | 23K | $35.72 | $825K | 94K |
| 2025-12-17 | Chi Michael | Chief Operating Officer | Sell | 14K | $36.71 | $505K | 305K |
| 2025-12-17 | Carroll Patrick Harrison | Chief Medical Officer | Sell | 10K | $36.71 | $368K | 170K |
| 2025-12-17 | Becklund Irene | PAO | Sell | 8K | $36.71 | $309K | 2K |
| 2025-12-17 | Autor Deborah M. | Chief Policy Officer | Sell | 7K | $36.71 | $259K | 6K |
| 2025-12-09 | Perez Garcia Andrea G | n/a | Sell | 3K | $39.17 | $98K | 80K |
| 2025-12-01 | Chi Michael | Chief Operating Officer | Gift | 5K | $0.00 | $0 | 287K |
| 2025-11-28 | Dudum Andrew | Chief Executive Officer | Gift | 1.1M | $0.00 | $0 | 0 |
| 2025-11-24 | Boughton Soleil | Chief Legal Officer | Sell | 3K | $35.22 | $93K | 153K |
| 2025-11-17 | Okupe Oluyemi | Chief Financial Officer | Sell | 23K | $36.81 | $853K | 70K |
| 2025-11-17 | Okupe Oluyemi | Chief Financial Officer | Option exercise | 16K | $5.01 | $78K | 93K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Planned sales (Form 144)
Newest first. JSON4 Form 144 notices on file for HIMS worth $1.4M at the prices reported; 4 in the last 90 days worth $1.4M. Latest: Boughton Soleil filed on 2026-09-02 to sell 3,458 shares ($98K) from 2026-09-02.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-02 | Boughton SoleilOfficer | 3K | $98K | 0.002% | 2026-09-02 | Fidelity Brokerage Services LLC |
| 2026-08-19 | Boughton SoleilOfficer | 25K | $692K | 0.011% | 2026-08-19 | Fidelity Brokerage Services LLC |
| 2026-08-18 | Autor Deborah M.Officer, Director | 17K | $467K | 0.007% | 2026-08-18 | Fidelity Brokerage Services LLC |
| 2026-07-22 | Pendarvis ChristianeFormer Director | 4K | $113K | 0.002% | 2026-07-22 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person, newest filing first. JSON1 holder above 5% has filed on HIMS, 1 on Schedule 13D (active intent). The largest reported stake is Andrew Dudum at 9.4% of the class (22,610,002 shares), filed 2026-08-31 for an event on 2026-08-27.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-31 | 13D/Ano. 4 | Andrew Dudumindividual | 22.6M | 9.4% | 2026-08-27 |
13F holders
Tracked managers holding HIMS at their latest 13F. JSON6 of the 30 tracked managers held HIMS at their latest 13F, $610.8M in total at quarter-end prices. Citadel Advisors is the largest at $348.1M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 10.0M | $348.1M | 0.04% | -1.8M |
| D. E. Shaw & Co. | 2026-06-30 | 5.2M | $179.4M | 0.09% | +2.7M |
| Point72 Asset Management | 2026-06-30 | 1.5M | $52.9M | 0.06% | +1.3M |
| Millennium Management | 2026-06-30 | 670K | $23.2M | 0.01% | -1.0M |
| AQR Capital Management | 2026-06-30 | 210K | $7.1M | 0.00% | +139K |
| Bridgewater Associates | 2026-06-30 | 7K | $244K | 0.00% | -35K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 2026 (quarter ended 2026-06-30) Hims & Hers Health, Inc. reported revenue of $753.2M, up 38.2% from the same quarter a year earlier, and net loss of $86.3M (-0.37 diluted EPS). In FY 2025 it generated $300.0M of operating cash flow and spent $90.0M on buybacks.
- Cash
- $609.8M
- Equity
- $324.1M
- Total assets
- $3.63B
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $753.2M | -$86.3M | -11.5% | -0.37 |
| Q1 2026 | 2026-03-31 | $608.1M | -$92.1M | -15.1% | -0.40 |
| Q4 2025derived | 2025-12-31 | $617.8M | n/a | n/a | n/a |
| Q3 2025 | 2025-09-30 | $599.0M | $15.8M | 2.6% | 0.06 |
| Q2 2025 | 2025-06-30 | $544.8M | $42.5M | 7.8% | 0.17 |
| Q1 2025 | 2025-03-31 | $586.0M | $49.5M | 8.4% | 0.20 |
| Q4 2024derived | 2024-12-31 | $481.1M | n/a | n/a | n/a |
| Q3 2024 | 2024-09-30 | $401.6M | $75.6M | 18.8% | 0.32 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2.35B | n/a | $300.0M | n/a | $90.0M | n/a |
| FY 2024 | 2024-12-31 | $1.48B | n/a | $251.1M | n/a | $83.0M | n/a |
| FY 2023 | 2023-12-31 | $872.0M | n/a | $73.5M | n/a | $2.0M | n/a |
| FY 2022 | 2022-12-31 | $526.9M | n/a | -$26.5M | n/a | $0 | n/a |
| FY 2021 | 2021-12-31 | $271.9M | n/a | -$34.4M | n/a | $0 | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30.
What this page is
Hims & Hers Health, Inc. in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows Hims & Hers Health, Inc. (HIMS), SEC CIK 1773751, listed on NYSE, classified by the SEC as services-offices & clinics of doctors of medicine. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-14.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-14.JSON and CSV
- Planned sales
- SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-09-02.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-08-31.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-08-19.JSON and CSV
- Company record
- EDGAR filing index for CIK 1773751Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 12 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-offices & clinics of doctors of medicine
- CRWVCoreWeave, Inc.
- UTHRUNITED THERAPEUTICS Corp
- TEAMAtlassian Corp
- CVNACARVANA CO.
- CRWDCrowdStrike Holdings, Inc.
- RCGRENN Fund, Inc.
- APPAppLovin Corp
- SESea Ltd
- VICRVICOR CORP
- GOOGLAlphabet Inc.
- ANETArista Networks, Inc.
- CRMSalesforce, Inc.
- CRDOCredo Technology Group Holding Ltd
- RDDTReddit, Inc.
- NVDANVIDIA CORP
- METAMeta Platforms, Inc.
- APPFAPPFOLIO INC
- ALABAstera Labs, Inc.
- STXSeagate Technology Holdings plc
- IOTSamsara Inc.
- WALWESTERN ALLIANCE BANCORPORATION
- CPIXCUMBERLAND PHARMACEUTICALS INC
- DASHDoorDash, Inc.
- SNOWSnowflake Inc.
Datasets
Frequently Asked Questions
How much of HIMS is sold short?
What is HIMS's daily short volume?
Does HIMS have fails to deliver?
Are HIMS insiders buying or selling?
Have HIMS insiders filed to sell?
Who owns more than 5% of HIMS?
What did HIMS report last quarter?
Which funds hold HIMS?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.